CLOs on the Move

PWNHealth

www.pwnhealth.com

 
PWNHealth is a national clinician network working to improve early detection and prevention of disease using advanced diagnostics and telehealth. Our model enables safe and easy access to diagnostic testing, ensuring clinical validity, utility, quality consumer education, access to clinicians, and the ability to implement national programs seamlessly. Our solutions provide the clinical, legal, and technological framework to facilitate population-scale testing across key healthcare markets. Through integration with more than 80 CLIA-certified labs and support of over 3,000 test types, we are shaping a new paradigm in healthcare, servicing all 50 states and Puerto Rico. We believe that empowering people ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.pwnhealth.com
  • 123 West 18th Street 8th Floor
    New York, NY USA 10011
  • Phone: 888.362.4321

Executives

Name Title Contact Details
Catherine Capeless
General Counsel Profile
Joaquin Gamboa
Chief Legal Officer Profile

Similar Companies

Cardinal Fitness

Cardinal Fitness is a Merrillville, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lee Pharmaceuticals

Lee Pharmaceuticals is an established manufacturer of quality lip balm, saline nasal spray and OTC products. We are aggressively pursuing the Private Label Lip Balm and OTC business with our products that are national brand equivalent.

American Society of Breast Disease

American Society of Breast Disease is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Foundation Fighting Blindness

The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases. The Foundation is a beacon for those affected by these blinding diseases. Join the fight and help us accelerate our mission.

Kite Pharma

Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.